Eiger BioPharmaceuticals, Inc.
NASDAQ:EIGR
1.725 (USD) • At close September 17, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -74.963 | -96.776 | -33.917 | -65.051 | -70.252 | -52.391 | -42.448 | -47.087 | -44.413 | -33.853 | -20.091 | -15.871 | -6.99 |
| Afschrijvingen & Amortisatie
| 0.75 | 0.842 | 0.799 | 0.645 | 0.486 | 0.054 | 0.041 | 0.023 | 0.504 | 0.153 | 0.067 | 0.064 | 0.073 |
| Uitgestelde Inkomstenbelasting
| -1.104 | 0 | -45.497 | 0.124 | -0.467 | -0.426 | -0.253 | 0.124 | 0.388 | 0.577 | 0.417 | 0.124 | 0.092 |
| Aandelen Gebaseerde Vergoedingen
| 5.008 | 8.317 | 7.901 | 5.973 | 5.679 | 5.007 | 4.243 | 3.19 | 3.028 | 3.319 | 1.388 | 0.298 | 0 |
| Verandering in Werkkapitaal
| -5.733 | 0.481 | -1.341 | -5.897 | -0.009 | 4.065 | -0.321 | 1.719 | -2.126 | 0.083 | 1.947 | 0.612 | -0.126 |
| Vorderingen
| 0.084 | 0.828 | -2.576 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 1.626 | -1.367 | -2.424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -6.835 | 1.152 | 3.234 | -1.899 | 0.584 | 2.647 | 0.544 | 0.699 | -4.268 | 2.935 | 1.843 | 0 | 0 |
| Overig Werkkapitaal
| -0.608 | -0.132 | 0.425 | -3.998 | -0.593 | 1.418 | -0.865 | 1.02 | 2.142 | -2.852 | 0.104 | 0 | 0 |
| Overige Niet-Contante Posten
| 1.494 | 4.126 | 0.713 | 1.021 | 0.949 | 1.02 | 0.366 | 4.061 | 1.528 | 0.462 | 0.076 | 0.136 | 1.123 |
| Kasstroom uit Operationele Activiteiten
| -74.548 | -83.01 | -71.342 | -63.185 | -63.614 | -42.671 | -38.372 | -37.97 | -41.091 | -29.259 | -16.196 | -14.637 | -5.611 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.234 | -0.34 | -48.732 | -0.258 | -0.475 | -0.142 | -0.044 | -0.058 | -0.235 | -0.739 | -0.087 | -0.048 | -0.002 |
| Netto Overnames
| 0 | -9.972 | 46.493 | 44.529 | 15.996 | 0 | 0 | 28.018 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -19.388 | -75.101 | -84.647 | -128.295 | -96.267 | -57.193 | -24.524 | -34.154 | 0 | -90.659 | -17.86 | -26.751 | 0 |
| Verkoop/verval van Beleggingen
| 93.85 | 85.073 | 99.63 | 83.766 | 80.271 | 28.25 | 47.025 | 2 | 70.327 | 30.21 | 28.801 | 4.966 | 0 |
| Overige Investeringsactiviteiten
| 0 | 9.972 | 48.788 | -44.529 | -15.996 | -28.943 | 0.2 | 28.018 | 0.277 | 0 | 0 | 0 | 0.037 |
| Kasstroom uit Investeringsactiviteiten
| 74.228 | 9.632 | 61.532 | -44.787 | -16.471 | -29.085 | 22.657 | -4.194 | 70.369 | -61.188 | 10.854 | -21.833 | 0.035 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| 0 | 5.448 | 0 | 0 | -1.667 | 0 | 0 | -14.759 | -10 | 0 | 0 | -0.111 | -0.018 |
| Uitgifte van Gewone Aandelen
| 0 | 71.507 | 3.342 | 0 | 53.194 | 0 | 0 | 50.337 | 0.826 | 95.028 | 0 | 0 | 0.09 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0.13 | 0 | 0 | 3.172 | 0 | -7.661 | -1.693 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -0.015 | 0 | 0 | 97.463 | 6.669 | 100.983 | 19.994 | 11.633 | -1.762 | 9.612 | 1.953 | 49.954 | 4.4 |
| Kasstroom uit Financieringsactiviteiten
| 0.041 | 76.955 | 3.342 | 97.463 | 58.196 | 100.983 | 19.994 | 65.142 | -10.936 | 96.979 | -0.596 | 49.843 | 4.472 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -0.358 | 3.577 | -6.643 | -10.509 | -21.889 | 29.227 | 4.279 | 22.978 | 18.342 | 6.532 | -5.938 | 13.373 | -1.104 |
| Kaspositie aan het Einde van de Periode
| 25.44 | 25.798 | 22.221 | 28.864 | 39.373 | 61.262 | 32.035 | 27.756 | 32.777 | 14.435 | 7.903 | 13.841 | 0.6 |